Cornerstone Capital Management Holdings’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | $6.49M | Buy |
54,244
+5,883
| +12% | +$703K | 0.05% | 385 |
|
|
2017
Q3 | $6.78M | Sell |
48,361
-2,216
| -4% | -$311K | 0.05% | 361 |
|
|
2017
Q2 | $6.15M | Buy |
50,577
+11,730
| +30% | +$1.43M | 0.05% | 387 |
|
|
2017
Q1 | $4.71M | Sell |
38,847
-147
| -0.4% | -$17.8K | 0.04% | 477 |
|
|
2016
Q4 | $4.77M | Sell |
38,994
-3,213
| -8% | -$393K | 0.04% | 490 |
|
|
2016
Q3 | $5.17M | Sell |
42,207
-6,075
| -13% | -$744K | 0.04% | 456 |
|
|
2016
Q2 | $5.64M | Hold |
48,282
| – | – | 0.05% | 424 |
|
|
2016
Q1 | $6.72M | Sell |
48,282
-1,015
| -2% | -$141K | 0.06% | 373 |
|
|
2015
Q4 | $9.4M | Sell |
49,297
-1,239
| -2% | -$236K | 0.08% | 283 |
|
|
2015
Q3 | $7.9M | Sell |
50,536
-541
| -1% | -$84.6K | 0.07% | 306 |
|
|
2015
Q2 | $9.23M | Buy |
51,077
+4,515
| +10% | +$816K | 0.08% | 277 |
|
|
2015
Q1 | $8.07M | Buy |
46,562
+522
| +1% | +$90.5K | 0.08% | 323 |
|
|
2014
Q4 | $8.52M | Buy |
46,040
+1,821
| +4% | +$337K | 0.09% | 310 |
|
|
2014
Q3 | $7.33M | Sell |
44,219
-185
| -0.4% | -$30.7K | 0.08% | 324 |
|
|
2014
Q2 | $6.94M | Sell |
44,404
-3,706
| -8% | -$579K | 0.08% | 341 |
|
|
2014
Q1 | $7.32M | Buy |
48,110
+1,190
| +3% | +$181K | 0.09% | 315 |
|
|
2013
Q4 | $6.23M | Sell |
46,920
-1,020
| -2% | -$136K | 0.07% | 354 |
|
|
2013
Q3 | $5.57M | Buy |
47,940
+192
| +0.4% | +$22.3K | 0.07% | 371 |
|
|
2013
Q2 | $4.41M | Buy |
+47,748
| New | +$4.41M | 0.05% | 410 |
|